Skip to Main Content

Paper Details

Protective Efficacy of Rhesus Adenovirus COVID-19 Vaccines against Mouse-Adapted SARS-CoV-2.
J Virol
11
2021
COVID-, COVID-19, COVID-19 disease, Mouse, RhAd52, Rhesus Adenovirus, SARS, SARS-CoV, SARS-CoV-2, SARS-CoV-2 virus, chimpanzee, human, humans, mice, mouse, rhesus, rhesus adenovirus
Author NameAffiliation
Lisa E GralinskiUniversity of North Carolina at Chapel Hillgrid.10698.36
Lisa E GralinskiUniversity of North Carolina at Chapel Hillgrid.10698.36
Sarah R LeistUniversity of North Carolina at Chapel Hillgrid.10698.36
Ralph S BaricUniversity of North Carolina at Chapel Hillgrid.10698.36
Ralph S BaricUniversity of North Carolina at Chapel Hillgrid.10698.36
Dan H BarouchCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Centergrid.239395.7, Harvard Medical School
Dan H BarouchRagon Institute of MGH
Dan H BarouchHarvard Medical School
Dan H Barouch
  • 1 - 9

Datasets

Release 1.2